Research
Our partners
Clinical trial finds new immunotherapy improves MS symptoms
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has found that it improved symptoms and quality of life for most patients.
Advancements in research
Highlights of the latest developments in research across our health service